Spyre Therapeutics, Inc. - Common Stock (SYRE)
Seasonality Analysis
Spyre Therapeutics, Inc. - Common Stock Annual Seasonality Statistics
Spyre Therapeutics, Inc. - Common Stock Monthly Seasonality Performance
| Month | Avg Return | Win Rate | Strength |
|---|---|---|---|
| January | 2.73% | Weak | |
| February | 0.68% | Weak | |
| March | 2.67% | Weak | |
| April | -0.83% | Very Weak | |
| May WORST | -6.40% | Weak | |
| June BEST | 11.71% | Weak | |
| July | -1.75% | Weak | |
| August | 11.56% | Very Strong | |
| September | 3.53% | Moderate | |
| October | 10.29% | Weak | |
| November | -1.11% | Weak | |
| December | -4.19% | Weak |
Spyre Therapeutics, Inc. - Common Stock 2026 vs Historical Pattern
Spyre Therapeutics, Inc. - Common Stock Interactive Seasonality Chart
Spyre Therapeutics, Inc. - Common Stock Pattern Scanner
Spyre Therapeutics, Inc. - Common Stock Seasonal Historical Performance
About Spyre Therapeutics, Inc. - Common Stock (SYRE) Seasonality
Spyre Therapeutics, Inc. - Common Stock (SYRE) has been analyzed using 11 years of historical data to identify seasonal patterns. Classified under Stocks, Spyre Therapeutics, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.
The strongest month for Spyre Therapeutics, Inc. - Common Stock is historically June, with an average return of 11.71% and a win rate of 50%. Conversely, May tends to be the weakest month, averaging -6.40% return.
Looking at the full calendar year, Spyre Therapeutics, Inc. - Common Stock has an average annual return of 28.90% with an overall monthly win rate of 47.3%. Out of 12 months, 7 typically show positive average returns.
The seasonal pattern for Spyre Therapeutics, Inc. - Common Stock has a consistency score of 35.7 (Poor), based on 11 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.
Spyre Therapeutics, Inc. - Common Stock Seasonality FAQ
What is the best month to buy Spyre Therapeutics, Inc. - Common Stock (SYRE)?
Historically, June has been the best month for Spyre Therapeutics, Inc. - Common Stock, with an average return of 11.71% and a win rate of 50%. However, past performance does not guarantee future results.
What is the worst month for Spyre Therapeutics, Inc. - Common Stock (SYRE)?
Based on historical data, May has been the weakest month for Spyre Therapeutics, Inc. - Common Stock, with an average return of -6.40%. This is a historical observation and does not guarantee future results.
How reliable is SYRE seasonality data?
The seasonality analysis for Spyre Therapeutics, Inc. - Common Stock is based on 11 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.
How can I use Spyre Therapeutics, Inc. - Common Stock seasonality in my trading?
Use Spyre Therapeutics, Inc. - Common Stock (SYRE) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.